Global Advanced Parenteral Medical Nutrition market Size (2023-2030)

In 2022, the Global Advanced Parenteral Medical Nutrition Market was valued at $2.8 billion, and is projected to reach a market size of $5.93 billion by 2030. Over the forecast period of 2023-2030, market is projected to grow at a CAGR of 9.84%.

Market Overview:

Advanced Parenteral Medical Nutrition is a medical process where food is fed to a patient and injected directly into the veins. The nourishment that can be injected includes protein, carbohydrates, fats, minerals, vitamins, and electrolytes. This is done for patients who are unable to absorb food and nutrients naturally through the mouth and prevent the chances of malnutrition. The digestive system of the patient is not functional during parenteral feeding. Therefore, the diet should be taken care of properly before injecting it into the patients to avoid difficulties in digestion which may play an important role in their recovery.

The Advanced Parenteral Medical Nutrition market has evolved greatly with time, they are now safer and more accessible with the introduction of new and advanced technologies in the healthcare sector. The process has now become more simplified and has decreased the chances of infection along with other infection control methods in the coming years.

COVID-19 Impact on the Advanced Parenteral Medical Nutrition Market:

The COVID-19 outbreak critically impacted economies and industries in various countries due to lockdowns and global business shutdowns. The healthcare and pharmacy industrieswerethe major industries that faced serious disruptions such as supply chain breaks, technology events, and office shutdowns as a result of this outbreak. It hampered the overall growth of the market in three major ways: by affecting production and demand, its financial impact on the manufacturing industry, by supply-chain disruptions. Also, due to shutdowns and the restrictive lifestyle that followed the lockdown, lifestyle became more sedentary exposing people to more disease-prone environments. To improve the healthcare situation, the government alongside regulatory authorities of several economiesstarted updating the guidelines for the mode of providing nutrition and food to COVID-19 patients. This is predicted to slightly raise the growth of the global advanced parenteral nutrition market over the forecast period, 2023-2028.

Market Drivers:

The rising prevalence of malnutrition especially among children is anticipated to boost the growth of the market over the forecast period:

The widespread prevalence of malnutrition among children is likely to foster the growth of the global advanced parenteral medical nutrition market. According to a report by the World Health Organization, published on June 9, 2021, and United Nations Children’s Fund (UNICEF) in 2020, globally, 1.9 billion adults areobese, while 462 million adults are underweight, 149 million children, under the age of fivewere observed to be stunted, 45 millionwasted, and 38.9 million were obese and almost around 45% of deaths among children, under the age of five years, occur mostly due to malnutrition. These are the factors that are likely to affect the global advanced parenteral medical nutritionmarket positively augmenting the growth size.

Surging government interest and initiatives in the issuance of new guidelines to improve the parenteral medical nutrition facilities to boost the market growth size:

The rising number of government initiatives aimed at medical nutrition isanticipated to boost the global advanced parenteral medical nutrition market growth during the forecasted timeline. Several medical authoritiesand government notices are being released to support the medical facility and improve the overall system.

Surging investments in the healthcare industry are fostering the market:

The rising investments in the healthcare industry are helping in improving its infrastructure along with government organizations implementing several strategies and initiatives to improve the status of healthcare worldwide.

The increasing geriatric population is fostering the demand for the advanced parenteral medical nutrition in the market:

The surging geriatric population is estimated to boost the market's growth rate. Bowel movement disorders are becoming increasingly common as people age. This is because of their body’s inability to digest meals. Muscle loss and inefficient function may lead to major problems. As a result, senior citizens are rapidly using this advanced parenteral nutrition method for intaking the food driving the market.

Market Restraints:

Lack of healthcare awareness in underdeveloped and developing countries is slowing down the market growth:

The market size is restrained in developing nations as well as in some underdeveloped countries as health awareness remains lower. Many people in developing countries are known to neglect their regular health check-ups and have really low knowledge levels about complications associated with neglecting them. This makes it difficult for all the players to have any profit in the developing regions narrowing down the scope and hindering the growth of the advanced parenteral medical nutrition market.

ADVANCED PARENTERAL MEDICAL NUTRITION  MARKET REPORT COVERAGE:

This research report on the Advanced Parenteral Medical Nutrition Market has been segmented and sub-segmented based on Nutrient Type, Region, Companies.

Advanced Parenteral Medical Nutrition Market – By Nutrient Type.

• Carbohydrates
• Parenteral Lipid Emulsion
• Single Dose Amino Acid Solution
• Vitamins & Minerals
• Trace Elements

Based on the nutrient type, the global advanced parenteral medical nutrition market is segmented into 5 segments – Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Vitamins & Minerals, and Trace Elements.

In 2022, the Single Dose Amino Acid Solution segment accounts for the majority revenue shareholder with more than 30.5%.The formulations of mixed amino acids produce essential and nonessential amino acids; therefore, they act ascomprehensive parenteral medical nutrition for the overall biological functioning of the body.

The Parenteral Lipid Emulsion segment is anticipated to project the fastest growth during the forecast period, owing to the increasing adoption of parenteral nutrition over enteral nutrition in COVID-19 patients, shorter hospital stays, and reduced risk of infection, thereby driving the segment growth.

Advanced Parenteral Medical Nutrition Market – By Region.

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle-east and Africa

Based on the region, the global advanced parenteral medical nutrition market is segmented into 5 major regions- North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is anticipated to hold dominance in the global advanced parenteral nutrition market over the forecasted period, due to the rising number of product launches or approvals.

Furthermore, due to business expansion throughmassive investments in manufacturing units by the key market players, Europe is likely to witness remarkable growth in the global parenteral medical nutrition market over the forecast period.

Advanced Parenteral Medical Nutrition Market – By Companies.

1. Baxter
2. Allergan
3. Actavis Inc.
4. Otsuka Pharmaceutical Factory, Inc.
5. Grifols, S.A.
6. B. Braun Melsungen AG
7. Vifor Pharma
8. Fresenius Kabi AG
9. Sichuan Kelun Pharmaceutical Co., Ltd.
10. Pfizer Inc. (Hospira Inc.)

Continuous advancements and investments from key operating major players for the development of advanced Parenteral Medical Nutrition solutions have led them to gain a lucrative edge in the market, thereby driving the global market growth.

Recent Key Industry Developments:

• January 2020, Fresenius Kabi completed its clinical trial for SmofKabiven, their new launch in the range of lipid emulsions to improve their current product portfolio to sustain their position in the market.